Bioavailability and pharmacokinetics of phenytoin during pregnancy.

Abstract:

:Five epileptic women needing to commence phenytoin therapy during pregnancy received a single intravenous and a single oral dose of phenytoin several days apart before starting regular intake of the drug. Plasma phenytoin concentration - time data were analysed by three different pharmacokinetic techniques. However assessed, the mean oral bioavailability of the drug proved to be about 90% of the intravenous bioavailability. This finding makes it unlikely that impaired bioavailability accounts for the increase in oral phenytoin dosage necessary in pregnancy to maintain plasma phenytoin concentrations at pre-pregnancy values. Phenytoin clearance in the pregnant subjects was approximately double the published values for phenytoin clearance in non-pregnant persons. This suggests that increased (metabolic) clearance accounts for the increased phenytoin dosage requirement of pregnancy.

journal_name

Eur J Clin Pharmacol

authors

Lander CM,Smith MT,Chalk JB,de Wytt C,Symoniw P,Livingstone I,Eadie MJ

subject

Has Abstract

pub_date

1984-01-01 00:00:00

pages

105-10

issue

1

eissn

0031-6970

issn

1432-1041

journal_volume

27

pub_type

杂志文章
  • Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.

    abstract::Deuterated methadone (M-d3) and GCMS were used to study the pharmacokinetics of methadone (M) during the induction stage of methadone maintenance treatment (MMT). A pulse dose of M-d3 was given on Days 1 and 25 of two dosage regimens, one with a continuous 30 mg dose (n = 6), and the other with 30 mg for 10 days, foll...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00548404

    authors: Nilsson MI,Anggård E,Holmstrand J,Gunne LM

    更新日期:1982-01-01 00:00:00

  • Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles.

    abstract:OBJECTIVES:Administration of fluvoxamine (FLV) with concomitant benzodiazepines is common in clinical situations. We studied the effects of the coadministration of FLV on plasma concentrations of alprazolam (ALP). We also studied the effects of CYP2C19(*)2 or CYP2C19(*)3 on these drug interactions. METHODS:The subject...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-003-0563-9

    authors: Suzuki Y,Shioiri T,Muratake T,Kawashima Y,Sato S,Hagiwara M,Inoue Y,Shimoda K,Someya T

    更新日期:2003-04-01 00:00:00

  • Baclofen in the elderly stroke patient its side-effects and pharmacokinetics.

    abstract::A double blind crossover trial of baclofen against placebo in elderly stroke patients was discontinued because the drug produced an unacceptably high level of drowsiness. In a subsequent study baclofen 10 mg was given orally to 12 elderly stroke patients, and drug concentrations measured from a series of plasma sample...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00613463

    authors: Hulme A,MacLennan WJ,Ritchie RT,John VA,Shotton PA

    更新日期:1985-01-01 00:00:00

  • Capecitabine plus oxaliplatin (XELOX) compared with 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in advanced gastric cancer: meta-analysis of randomized controlled trials.

    abstract:PURPOSE:The study aims to compare the efficacy and safety of capecitabine plus oxaliplatin (XELOX) with 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in patients with advanced gastric cancer. METHODS:Five databases were searched up to June 2014, without language restrictions. The outcomes included overall respo...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,meta分析

    doi:10.1007/s00228-015-1828-9

    authors: Xu HB,Huang F,Su R,Shen FM,Lv QZ

    更新日期:2015-05-01 00:00:00

  • The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.

    abstract::We have studied the antiaggregatory effect of fenflumizole, a new non-steroidal antiinflammatory imidazole derivative, in ten patients with unstable angina pectoris. We have measured the aggregation induced by arachidonic acid (AA), ADP, and collagen, and serum or plasma concentrations of beta-thromboglobulin (beta-TG...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00606628

    authors: Grauholt AM,Grande P,Wadt J

    更新日期:1987-01-01 00:00:00

  • Pharmacokinetics of phenylethylmalonamide (PEMA) in elderly men.

    abstract::The pharmacokinetics of phenylethylmalonamide (PEMA) were studied in 6 elderly men after oral administration of a single 400 mg dose. Peak PEMA serum levels were obtained within 4 h of intake, half-life values ranged from 30.7-57.9 h in these elderly men. The elimination half-life was twice as long when compared to a ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00637644

    authors: Streete JM,Berry DJ,Newberry JE,Crome P

    更新日期:1987-01-01 00:00:00

  • Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.

    abstract:BACKGROUND AND OBJECTIVES:Dosing of vancomycin in pediatric patients undergoing continuous venous-venous hemodiafiltration (CVVHDF) is challenging. Characterization of vancomycin pharmacokinetics can assist with dosing and attainment of goal serum concentrations. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS:Patient...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-019-02664-7

    authors: Moffett BS,Morris J,Munoz F,Arikan AA

    更新日期:2019-08-01 00:00:00

  • Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature.

    abstract:BACKGROUND:Spinal-cord injury (SCI) is a leading cause of neuropathic pain (NP). Current pharmaceutical treatments for NP in SCI patients are not effective. Two promising options are gabapentin (GP) and pregabalin (PB). Their predominant mechanism of action is believed to be the inhibition of calcium currents, leading ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-008-0523-5

    authors: Tzellos TG,Papazisis G,Amaniti E,Kouvelas D

    更新日期:2008-09-01 00:00:00

  • Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China.

    abstract:PURPOSE:In-hospital statin dosage-related effect remains unknown for patients with arteriosclerotic cardiovascular disease (ASCVD). This study aimed to determine the associations of different in-hospital intensive statins dosages with the prognosis for patients in the era of percutaneous coronary intervention (PCI). M...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-020-02966-1

    authors: Chen PY,Liu YH,Duan CY,Fan HL,Zeng LH,Guo W,Jiang L,Wei XB,He WF,Tao S,Guo ZQ,Chen JY,Tan N,He PC

    更新日期:2020-12-01 00:00:00

  • Effect of sparteine sulphate upon basal and nutrient-induced insulin and glucagon secretion in normal man.

    abstract::Infusion of a therapeutic dose of sparteine sulphate, increased the basal plasma insulin level and lowered plasma glucose. When an intravenous glucose tolerance test was performed with the infusion, the total insulin AUC was significantly larger than in absence of sparteine (2025 vs 1464 microU/ml X min), plasma gluco...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00637673

    authors: Sgambato S,Paolisso G,Passariello N,Varricchio M,D'Onofrio F

    更新日期:1987-01-01 00:00:00

  • Improved participants' understanding of research information in real settings using the SIDCER informed consent form: a randomized-controlled informed consent study nested with eight clinical trials.

    abstract:PURPOSE:This study aimed to test the applicability and effectiveness of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) across multiple clinical trials involving Thai research participants with various conditions. METHODS:A...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00228-016-2159-1

    authors: Koonrungsesomboon N,Tharavanij T,Phiphatpatthamaamphan K,Vilaichone RK,Manuwong S,Curry P,Siramolpiwat S,Punchaipornpon T,Kanitnate S,Tammachote N,Yamprasert R,Chanvimalueng W,Kaewkumpai R,Netanong S,Kitipawong P,Sritipsukh

    更新日期:2017-02-01 00:00:00

  • Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability.

    abstract:PURPOSE:Propofol anesthesia is usually accompanied by hypotensive responses, which are at least in part mediated by nitric oxide (NO). Arginase I (ARG1) and arginase II (ARG2) compete with NO synthases for their common substrate L-arginine, therefore influencing the NO formation. We examined here whether ARG1 and ARG2 ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-020-03059-9

    authors: Oliveira-Paula GH,Coeli-Lacchini FB,Ferezin LP,Ferreira GC,Pinheiro LC,Paula-Garcia WN,Garcia LV,Tanus-Santos JE,Lacchini R

    更新日期:2021-01-07 00:00:00

  • Lack of potentiation by cetirizine of alcohol-induced psychomotor disturbances.

    abstract::The possible interaction between cetirizine 2 HCl and alcohol was studied in a double-blind, cross-over trial in 36 healthy volunteers. The performance of each volunteer was tested with a battery of five objective psychometric tests, and their subjective feelings were evaluated by visual analogue scales, and by extens...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00615227

    authors: Doms M,Vanhulle G,Baelde Y,Coulie P,Dupont P,Rihoux JP

    更新日期:1988-01-01 00:00:00

  • Unwanted symptoms in depressed patients treated with viloxazine: an algorithm for identification of illness-related symptoms.

    abstract::Ninety-six depressed outpatients from 5 centres were given viloxazine 200-400 mg/day. The treatment produced significant clinical improvement as evaluated by the Hamilton Rating Scale for Depression. Thirteen patients dropped-out because of possible side effects. Many untoward symptoms were described by all the patien...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00613832

    authors: Maistrello I,Grassi G,Bertolino A,Valerio P,Pistollato G,Soverini S

    更新日期:1983-01-01 00:00:00

  • Effects of probenecid on enprofylline kinetics in man.

    abstract::Enprofylline 1 mg/kg, a new potent antiasthmatic xanthine derivative, which is mainly eliminated by renal excretion, was given intravenously to 6 normal subjects with and without oral pretreatment with 1 g probenecid. The latter caused a drop in the average total body clearance of enprofylline from 21 to 9.8 l/h, and ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00614308

    authors: Borgå O,Larsson R,Lunell E

    更新日期:1986-01-01 00:00:00

  • An analysis of the clinical development of drugs in Norway for the year 2000: the completion of research and publication of results.

    abstract:OBJECTIVE:In Norway, very little data are available on the relation between the total number of research projects on the clinical development of drugs that have been started, the number of these projects in which the research phase has been completed and the number of projects for which results have been published. The...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-008-0601-8

    authors: Hole OP,Nitter-Hauge S,Cederkvist HR,Winther FO

    更新日期:2009-03-01 00:00:00

  • Protein binding of salicylate in cutaneous hepatic porphyria.

    abstract::(1) Plasma protein binding of salicylate was studied in 14 patients with cutaneous hepatic porphyria (CHP) and 11 normal subjects using ultrafiltration with centrifugation (membrane cones) and continuous ultrafiltrations. (2) Albumin and haemoglobin levels were significantly reduced in patients with CHP, and salicylat...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00716368

    authors: Steele WH,Boobis SW,Moore MR,Goldberg A,Brodie MJ,Summer DJ

    更新日期:1978-06-19 00:00:00

  • Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.

    abstract::The plasma levels and myocardial content of verapamil and its metabolites norverapamil, N-dealkylverapamil and N-dealkylnorverapamil were determined in 15 patients with valvular [3] or ischaemic [12] heart disease. The mean myocardial plasma concentration ratio (M/P) was 7.05 for verapamil, 11.45 for norverapamil, 8.9...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00607910

    authors: Padrini R,Barbieri E,Piovan D,Toffoli M,Motta A,Trevi GP,Ferrari M

    更新日期:1985-01-01 00:00:00

  • Protein binding of drugs in plasma, interstitial fluid and tissues: effect on pharmacokinetics.

    abstract::Drug binding in the interstitial fluid as well as in the plasma must be taken into account when considering the pharmacokinetics of drugs which are highly bound to plasma proteins and have a relatively small apparent volume of distribution (V). The half-life and apparent volume of distribution of such a drug can be af...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00609592

    authors: Faed EM

    更新日期:1981-01-01 00:00:00

  • Exercise increases plasma concentrations of (R)- and (S)-propranolol.

    abstract:OBJECTIVE:We recently reported a highly stereoselective increase in plasma concentrations of (S)-atenolol during exercise which is most likely due to a release of the drug from adrenergic cells. The objective of the present study was to investigate the influence of physical exercise on plasma concentrations of the (R)-...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050119

    authors: Stoschitzky K,Schumacher M,Stark G,Dimai HP,Stauber R,Stoschitzky P,Krejs GJ,Klein W,Lindner W

    更新日期:1996-01-01 00:00:00

  • Effect of itraconazole on cerivastatin pharmacokinetics.

    abstract:OBJECTIVE:To determine the effects of itraconazole, a potent inhibitor of CYP3A4, on the pharmacokinetics of cerivastatin, a competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. METHODS:A randomized, double-blind, cross-over study design with two phases, which were separated by a washout pe...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s002280050566

    authors: Kantola T,Kivistö KT,Neuvonen PJ

    更新日期:1999-01-01 00:00:00

  • Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers.

    abstract:PURPOSE:To study the impact of gemfibrozil co-administration on the pharmacokinetics of sitagliptin in healthy Indian male volunteers. METHODS:A randomized open label two-period crossover study involving 12 healthy Indian male volunteers was conducted at a single center. In each phase, the volunteers were administered...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00228-011-1177-2

    authors: K P A,Meda VS,Kucherlapati VS,Dubala A,M D,P R AV,K E,B S

    更新日期:2012-05-01 00:00:00

  • Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.

    abstract:PURPOSE:The aim of this study was to assess the pharmacokinetics and protein binding of cefazolin in morbidly obese patients undergoing bariatric surgery, to study the influence of bodyweight measures and age on pharmacokinetic parameters and to evaluate unbound cefazolin concentrations over time in this population. M...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-011-1048-x

    authors: van Kralingen S,Taks M,Diepstraten J,van de Garde EM,van Dongen EP,Wiezer MJ,van Ramshorst B,Vlaminckx B,Deneer VH,Knibbe CA

    更新日期:2011-10-01 00:00:00

  • Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population.

    abstract:PURPOSE:Alcohol dependence is a public health problem worldwide, commonly associated with withdrawal symptoms for which diazepam is a frequently used drug. We studied the effect of CYP2C19 gene polymorphisms on diazepam loading dose requirement and time to reversal of acute alcohol withdrawal symptoms. We also studied ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-016-2061-x

    authors: Jose M,Mathaiyan J,Kattimani S,Adithan S,Chandrasekaran A

    更新日期:2016-07-01 00:00:00

  • Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.

    abstract:OBJECTIVE:The multidrug resistance gene 1 (MDR1) seems to play a role in the carcinogenesis of colorectal tumors. The importance of MDR1 SNPs 2677G > T/A in exon 21 and 3435C > T in exon 26 for cancer susceptibility, however, has not yet been clearly defined. METHODS:Two hundred and eighty-five colorectal cancer patie...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-006-0225-9

    authors: Osswald E,Johne A,Laschinski G,Arjomand-Nahad F,Malzahn U,Kirchheiner J,Gerloff T,Meisel C,Mrozikiewicz PM,Chernov J,Roots I,Köpke K

    更新日期:2007-01-01 00:00:00

  • Influence of triazolam on thermal heat balance in poor sleepers.

    abstract::The influence of a benzodiazepine (triazolam) on the body temperature of poor sleepers during nights disturbed by airplane noises has been examined. Subjects were divided into 3 groups each of 8 men. Following a double-blind design, Group A (controls) received a placebo for 6 consecutive nights, Group B received 0.25 ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00544042

    authors: Libert JP,Weber LD,Amoros C,Muzet A,Ehrhart J,Follenius M

    更新日期:1984-01-01 00:00:00

  • The liver metabolite S-422 of the hypolipidaemic drug benfluorex decreases cholesterol esterification in fibroblasts and monocyte-like cells.

    abstract::The effects of S-422 (1-(3-trifluoromethylphenyl)-2-[N-(2-hydroxyethyl) amino] propane), an hepatic metabolite of the hypolipidaemic drug Benfluorex, on lipid metabolism have been investigated in two experimental models: in human fetal lung fibroblasts, for study of the apo B/E receptor-mediated regulation of choleste...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00314964

    authors: Mazière JC,Mazière C,Auclair M,Mora L,Arnaud O

    更新日期:1991-01-01 00:00:00

  • Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports.

    abstract:BACKGROUND:Spontaneous reporting of adverse drug reactions (ADRs) is one approach to increasing our knowledge on the risks of drugs in clinical practice. Under-reporting is a shortcoming of this system. OBJECTIVES:To evaluate if repeated e-mails with attachments on ADR information can affect (1) the reporting of ADRs ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-008-0603-6

    authors: Johansson ML,Brunlöf G,Edward C,Wallerstedt SM

    更新日期:2009-05-01 00:00:00

  • Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France.

    abstract:PURPOSE:The quality of drug therapy is an important issue for nursing homes. This study aimed to assess the prevalence of polypharmacy and potentially inappropriate medications (PIMs) in a large sample of nursing home residents by using the data recorded during the preparation of pill dispensers. METHODS:This is a cro...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-016-2193-z

    authors: Herr M,Grondin H,Sanchez S,Armaingaud D,Blochet C,Vial A,Denormandie P,Ankri J

    更新日期:2017-05-01 00:00:00

  • Fabry disease and treatment with agalsidase alpha: unsuspected cardiac arrhythmia in two heterozygous women. In reference to pharmacovigilance.

    abstract:CASE REPORTS:Two women treated with agalsidase alpha for Fabry disease developed severe heart dysfunctions a few months after the beginning of enzyme replacement therapy (ERT). An adverse effect caused by the treatment was suspected; therefore we informed the French pharmacovigilance authorities about these two events....

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-007-0460-8

    authors: Mougenot P,Lidove O,Caillaud C,Arnaud P,Papo T

    更新日期:2008-06-01 00:00:00